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Web appendix 1 Comparison of participants invited but not attending, those attending clinical examination only and those 
with clinical and radiographic examination. 
Characteristics at baseline 
Invited,  
but not attending 
Attending clinical  
examination only 
Clinical and  
radiographic examination 
 n=1,653 n=1,100 n=1,603 
Age at baseline    
    35 to 54 years 530 (32%) 250 (23%) 394 (25%) 
    55 to 74 years 694 (42%) 511 (46%) 979 (61%) 
    75 years or older 429 (26%) 339 (31%) 230 (14%) 
Males 584 (35%) 422 (38%) 659 (41%) 
Lower social class (IIIM to V) 739 (52%) 526 (50%) 773 (48%) 
Previous joint replacement 95 (5.8%) 123 (11%) 86 (5.4%) 
Arterial hypertension 407 (25%) 258 (24%) 376 (23%) 
Cancer 51 (3.1%) 51 (4.6%) 59 (3.7%) 
Cardiovascular disease 448 (27%) 307 (28%) 354 (22%) 
Chronic inflammatory disease 539 (33%) 372 (34%) 512 (32%) 
COPD 298 (18%) 216 (20%) 267 (17%) 
Depression 218 (13%) 122 (11%) 157 (10%) 
Diabetes 73 (4.4%) 56 (5.1%) 56 (3.5%) 
Eye disease 161 (9.8%) 139 (13%) 127 (7.9%) 
Note that characteristics such as smoking status, type of OA, knee or hip pain, walking disability, type of analgesic intake 
and obesity are not available for all groups and not shown. COPD: chronic obstructive pulmonary disease. 
 
Web appendix 2 Association between overall mortality and baseline 
characteristics in 885 patients with OA of Kellgren/Lawrence grade ≥2. 
Characteristic Hazard ratio (95% CI) P value 
Age at baseline*  <0.001 
    55 to 74 years 14.0 (4.45 to 43.8)  
    75 years or older 46.7 (14.7 to 148)  
Males 1.50 (1.20 to 1.89) <0.001 
Lower social class  1.13 (0.91 to 1.41) 0.28 
Smoking  1.27 (0.97 to 1.67) 0.09 
Previous joint replacement 1.14 (0.80 to 1.63) 0.47 
Type of OA**  0.12 
    Hip only 1.37 (1.01 to 1.87)  
    Knee and hip 1.20 (0.93 to 1.54)  
Knee or hip pain 0.97 (0.77to 1.23) 0.78 
Walking disability 1.31 (1.02 to 1.69) 0.034 
Type of analgesic intake   
    Paracetamol 1.12 (0.85 to 1.49) 0.42 
    NSAIDs 0.88 (0.69 to 1.13) 0.33 
    Opioids 1.11 (0.82 to 1.49) 0.50 
Arterial hypertension 1.23 (0.97 to 1.56) 0.09 
Cancer 1.98 (1.23 to 3.21) 0.005 
Cardiovascular disease 1.40 (1.10 to 1.78) 0.006 
Chronic inflammatory disease 1.07 (0.86 to 1.34) 0.52 
COPD 1.14 (0.86 to 1.52) 0.36 
Depression 0.95 (0.65 to 1.38) 0.78 
Diabetes  1.81 (1.14 to 2.88) 0.011 
Eye disease 1.05 (0.77 to 1.44) 0.75 
Obesity 0.86 (0.67 to 1.11) 0.25 
Multivariable hazard ratios of overall mortality and 95% confidence intervals (95% CI) 
were derived from Cox proportional hazards models after multiple imputation of 
missing covariate data. Hazard ratios larger than 1 indicate a lower mortality in the 
reference category. P-values were derived from two-sided Wald tests. *Age 35 to 54 
as reference category. **Isolated knee osteoarthritis as reference category. COPD: 
chronic obstructive pulmonary disease. NSAIDs: Non-steroidal anti-inflammatory  
drugs. OA: Osteoarthritis.  
Web appendix 3 Association between all-cause mortality and baseline 
characteristics in 743 patients with complete covariate information. 
Characteristic Hazard ratio (95% CI) P value 
Age at baseline*  <0.001 
    55 to 74 years 18.0 (4.45 to 72.9)  
    75 years or older 56.8 (13.8 to 233)  
Males 1.68 (1.31 to 2.15) <0.001 
Lower social class  1.12 (0.88 to 1.42) 0.35 
Smoking  1.25 (0.91 to 1.71) 0.16 
Previous joint replacement 1.12 (0.76 to 1.67) 0.57 
Type of OA**  0.74 
    Hip only 1.08 (0.79 to 1.47)  
    Knee and hip 0.96 (0.73 to 1.26)  
Knee or hip pain 0.86 (0.67 to 1.10) 0.23 
Walking disability 1.28 (0.98 to 1.67) 0.06 
Type of analgesic intake   
    Paracetamol 1.21 (0.90 to 1.64) 0.21 
    NSAIDs 1.04 (0.81 to 1.34) 0.75 
    Opioids 0.91 (0.66 to 1.25) 0.56 
Arterial hypertension 1.15 (0.89 to 1.48) 0.28 
Cancer 2.27 (1.40 to 3.68) 0.001 
Cardiovascular disease 1.22 (0.93 to 1.59) 0.15 
Chronic inflammatory disease 1.04 (0.82 to 1.33) 0.73 
COPD 1.19 (0.87 to 1.63) 0.29 
Depression 1.04 (0.69 to 1.58) 0.84 
Diabetes  2.35 (1.50 to 3.67) <0.001 
Eye disease 1.16 (0.82 to 1.63) 0.40 
Obesity 0.83 (0.63 to 1.08) 0.17 
Multivariable hazard ratios of overall mortality and 95% confidence intervals (95% CI) 
were derived from Cox proportional hazards models. Hazard ratios larger than 1 indicate 
a lower mortality in the reference category. P-values were derived from two-sided Wald 
tests. *Age 35 to 54 as reference category. **Isolated knee osteoarthritis as reference 
category. COPD: chronic obstructive pulmonary disease. NSAIDs: Non-steroidal anti-
inflammatory drugs. OA: osteoarthritis. 
 
